Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heron

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|February 1, 2012
Bronchoalveolar lavage cell pattern from healthy human lungM Heron, J C Grutters, K M ten Dam-Molenkamp, et al.
Tissue Antigens|January 11, 2011
Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosisM Heron, C H M van Moorsel, J C Grutters, et al.
Genes and Immunity|July 24, 2009
Variation in IL7R predisposes to sarcoid inflammationM Heron, J C Grutters, C H M van Moorsel, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: selective inhibitors of Aurora B kinase with potent anti-tumor activityKevin M Foote, Andrew A Mortlock, Nicola M Heron, et al.
Clinical and Experimental Immunology|June 15, 2007
Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosisM Veltkamp, P A H M Wijnen, C H M van Moorsel, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitorsNicola M Heron, Malcolm Anderson, David P Blowers, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibitionAlexander G Dossetter, Jonathan Bowyer, Calum R Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosisRobert W Wilkinson, Rajesh Odedra, Simon P Heaton, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
A multicentre verification study of the QuantiFERON<sup>®</sup>-TB Gold Plus assayE D Pieterman, F G Liqui Lung, A Verbon, et al.
Journal of Medicinal Chemistry|June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritisAlexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|February 1, 2012
Bronchoalveolar lavage cell pattern from healthy human lungM Heron, J C Grutters, K M ten Dam-Molenkamp, et al.
Tissue Antigens|January 11, 2011
Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosisM Heron, C H M van Moorsel, J C Grutters, et al.
Genes and Immunity|July 24, 2009
Variation in IL7R predisposes to sarcoid inflammationM Heron, J C Grutters, C H M van Moorsel, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: selective inhibitors of Aurora B kinase with potent anti-tumor activityKevin M Foote, Andrew A Mortlock, Nicola M Heron, et al.
Clinical and Experimental Immunology|June 15, 2007
Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosisM Veltkamp, P A H M Wijnen, C H M van Moorsel, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitorsNicola M Heron, Malcolm Anderson, David P Blowers, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibitionAlexander G Dossetter, Jonathan Bowyer, Calum R Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosisRobert W Wilkinson, Rajesh Odedra, Simon P Heaton, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
A multicentre verification study of the QuantiFERON<sup>®</sup>-TB Gold Plus assayE D Pieterman, F G Liqui Lung, A Verbon, et al.
Journal of Medicinal Chemistry|June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritisAlexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.
Pageof 5